The author argues that, whatever important and rapid developments may
be taking place in imaging technologies, there will be a continuing ne
ed for X-ray enhancing agents for a considerable time to come. Areas i
n which there are current developments, such as non-ionic dimers and c
ompact dimers, are surveyed and a look to a possible future of blood p
ool and targetted agents is offered.